Trial Profile
Sertraline/[S,S]-Reboxetine Combination Versus Sertraline And [S,S]-Reboxetine Monotherapy In Major Depressive Disorder (MDD) In A Double-Blind, Placebo-Controlled, Eight Week Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Esreboxetine (Primary) ; Sertraline (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Pfizer
- 16 Apr 2008 New trial record.